Russell D. Cohen to Lupus Erythematosus, Systemic
This is a "connection" page, showing publications Russell D. Cohen has written about Lupus Erythematosus, Systemic.
Connection Strength
0.312
-
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data. J Crohns Colitis. 2020 Feb 10; 14(2):192-204.
Score: 0.158
-
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies. Inflamm Bowel Dis. 2013 Dec; 19(13):2778-86.
Score: 0.103
-
Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs. 2004; 64(16):1767-77.
Score: 0.052